Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesLittle Green Pharma Ltd

Little Green Pharma Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.058 AUD 0.00(0%)
Last update at 2026-11-06T04:00:00Z
VOLUME
32201
Market Cap
48.02M

Momentum Score

…

Little Green Pharma Ltd produces and sells cannabis-based medicinal products across Australia and Europe. The company also provides infrastructure to support plant genetics programs and the development of its flower portfolio. It sells its products through a network of wholesalers, pharmacies, clinics, and GPs (general practitioners). The company was founded in 2016 and is based in Wembley, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.06
Low
0.06
High
52 Week Price Range
0.06
Low
0.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Little Green Pharma is an Australian medicinal cannabis company that cultivates, manufactures and distributes cannabis-derived pharmaceutical products for the domestic market and selected export markets. Long-term growth may be supported by expanding production capacity, broader clinical adoption, regulatory approvals enabling exports and reimbursement, and product diversification, making it appear positioned as an integrated supplier in a regulated market.
Key risks include ongoing regulatory and reimbursement uncertainty and intensifying competition from both domestic and international producers which could pressure margins and growth.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.06
Dividend Yield
-
Revenue TTM
75.50M
Revenue Per Share
0.28
Gross Profit TTM
39.91M
Debt / Equity
0.06
ROE
14.01%
Net Debt
3.27M
ROCE
-2.26%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -1.54M -4.79M -8.15M -8.56M -18.05M
Net income -1.41M 3.32M -8.15M -9.21M -18.29M
Selling general administrative 14.91M 14.90M 15.96M 4.66M 19.25M
Selling and marketing expenses 6.71M 7.53M - 3.51M -
Gross profit 11.73M 25.26M 13.63M 11.98M 3.38M
Reconciled depreciation 3.81M 3.72M 3.08M 2.98M -
Ebit -1.96M -4.41M - -7.63M -22.37M
Ebitda 1.85M -0.68M - -4.64M -
Depreciation and amortization 3.81M 3.72M - 2.98M -
Operating income -1.96M -4.05M -9.16M -7.63M -18.96M
Other operating expenses 44.38M 40.37M - 32.98M -
Interest expense 0.55M 0.38M 0.60M 0.93M -
Tax provision -0.14M -8.12M 0.00M 0.00M 0.00M
Interest income 0.07M 0.32M -0.46M 1.44M 1.52M
Net interest income -0.49M -0.37M -0.46M -0.88M -
Extraordinary items - - 0.00M -0.65M -0.23M
Income tax expense -0.14M -8.12M - 4.32M -
Total revenue 42.42M 36.82M 25.63M 19.57M 10.53M
Total operating expenses 13.69M 25.16M 34.80M 25.39M -
Cost of revenue 30.70M 11.56M 12.00M 7.59M 7.15M
Total other income expense net 0.41M -1.24M 1.48M 2.75M -
Discontinued operations - - - - -0.31M
Net income from continuing ops -1.41M 3.32M -8.15M -8.56M -
Net income applicable to common shares - 3.32M -8.15M -9.21M -24.38M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 93.75M 96.12M 86.29M 98.62M 95.95M
Intangible assets 2.91M 3.36M 3.46M 3.64M 0.67M
Other current assets 3.08M 1.88M 1.59M 1.49M 1.00M
Total liab 10.72M 11.11M 9.03M 16.39M 20.47M
Total stockholder equity 83.03M 85.02M 77.26M 82.23M 75.48M
Deferred long term liab - - - 3.02M -
Other current liab 2.68M 0.99M - 0.06M 0.24M
Common stock 102.65M - - 101.18M 90.25M
Capital stock 102.65M 102.23M 101.93M 101.18M -
Retained earnings -30.32M -28.91M -32.24M -24.08M -14.88M
Other liab - - - - 0.02M
Good will 0.86M 0.86M - - -
Other assets - - - 3.41M 0.20M
Cash 1.42M 2.38M 4.97M 12.40M -
Cash and equivalents - - - 12.40M 20.09M
Total current liabilities 7.04M 8.74M 6.42M 11.04M 16.55M
Current deferred revenue - - - 1.07M -
Net debt 3.27M 0.71M - -0.53M -
Short term debt 1.26M - - 6.56M 11.88M
Short long term debt 1.13M 2.30M 2.36M 6.46M -
Short long term debt total 4.69M - - 11.87M -
Other stockholder equity - - - - 0.10M
Property plant equipment - - - 63.41M 59.58M
Total current assets 24.48M 22.71M 21.47M 31.15M 35.45M
Long term investments 0.04M 0.04M 0.36M 0.43M -
Net tangible assets - - - 81.61M 74.80M
Net receivables 6.08M 3.64M 2.63M 7.38M 5.60M
Long term debt 2.23M 0.78M 1.14M 5.28M 3.78M
Inventory 16.36M 13.83M 10.93M 8.91M 8.19M
Accounts payable 3.09M 3.93M 1.65M 3.36M 1.55M
Accumulated other comprehensive income 10.70M - - 5.13M -
Non currrent assets other 0.17M - - - -
Non current assets total 69.27M 73.41M 64.82M 67.47M -
Capital lease obligations 1.34M 1.58M 1.65M 0.12M -
Long term debt total - - - 5.31M 3.90M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -1.14M -2.80M -14.03M -
Change to liabilities - - - - -0.62M
Total cashflows from investing activities -0.95M -1.14M -2.80M -14.03M -10.21M
Net borrowings 0.14M -0.41M -4.68M - 4.90M
Total cash from financing activities 0.03M -0.53M -4.72M 13.03M 6.30M
Change to operating activities - - - - 0.81M
Net income -1.41M -4.79M -8.15M -9.21M -24.38M
Change in cash -0.95M -2.60M -7.46M -7.69M -26.91M
Begin period cash flow 2.38M 4.97M 12.40M 20.09M 40.27M
End period cash flow 1.42M 2.38M 4.97M 12.40M 20.09M
Total cash from operating activities 0.04M -0.92M 0.07M -6.94M -22.89M
Issuance of capital stock - - 0.06M 10.11M -
Depreciation 3.81M 3.72M 3.08M 2.98M 1.31M
Other cashflows from investing activities 0.05M -0.90M -1.36M -9.10M -0.25M
Dividends paid - - - 5.81M -
Change to inventory -0.07M -3.16M - - 0.93M
Change to account receivables -2.18M -0.05M - - -2.32M
Sale purchase of stock - - 0.06M -0.84M 1.05M
Other cashflows from financing activities -0.12M -0.12M 0.00M 11.54M -1.12M
Change to netincome - - - - 1.34M
Capital expenditures 0.83M 0.24M 1.44M 4.93M 10.17M
Change in working capital -5.84M -3.44M 1.70M -2.01M -0.89M
Other non cash items 3.48M 2.53M - - -
Free cash flow -0.79M -1.15M -1.38M -11.87M -

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
LGP
Little Green Pharma Ltd		 -
-%		 0.06 - 10.00 0.64 0.60 1.25 19.47
AFP
Aft Pharmaceuticals Ltd		 -
-%		 3.59 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 -
-%		 2.70 13.50 42.73 1.52 2.62 1.19 7.17
MVP
Medical Developments International Ltd		 -
-%		 0.40 40.00 166.67 1.06 0.79 0.57 7.45
SNT
Syntara Ltd		 -
-%		 0.02 - 20.45 5.10 2.18 6.32 -2.16

Profile*

Little Green Pharma Ltd

Little Green Pharma Ltd produces and sells cannabis-based medicinal products across Australia and Europe. The company also provides infrastructure to support plant genetics programs and the development of its flower portfolio. It sells its products through a network of wholesalers, pharmacies, clinics, and GPs (general practitioners). The company was founded in 2016 and is based in Wembley, Australia.

PO Box 101, Wembley, WA, Australia, 6913

61 13 0070 3999

https://www.littlegreenpharma.com

Name Title Year Born
Ms. Fleta Jennifer Solomon CEO & Director NA
Mr. Angus McDougall Caithness Exec. Director NA
Mr. Paul Long Chief Operating Officer NA
Mr. Alistair Warren B.A., L.L.B. Gen. Counsel & Company Sec. NA
Ms. Celia Young Head of Marketing NA
Ms. Gabriela Franz Head of Sales & Distribution EU NA
Dr. Leon Warne Head of Research & Innovation NA
Ms. Lina Sandberg Head of Quality NA
Ms. Melanie Pugliese Head of Engagment NA
Brian Westergaard Head of IT NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…